Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Glucose Homeostasis and Beta Cell Function in Pseudohypoparathyroidism

NCT03761290 is registered in ClinicalTrials.gov with Vanderbilt University Medical Center as lead sponsor.

NCT NCT03761290
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03761290 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Glucose Homeostasis and Beta Cell Function in Pseudohypoparathyroidism
Lead sponsor
Vanderbilt University Medical Center
Phase
Observational
Overall status
Terminated
Start date
June 19, 2019
Completion date
April 30, 2021
Enrollment
14 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

albright hereditary osteodystrophy, pseudohypoparathyroidism and pseudopseudohypoparathyroidism, pseudohypoparathyroidism type ia